IGFBP3 was not significantly associated with breast-cancer risk in any study of premenopausal women, and was significantly positively associated with risk in three out of 15 studies of postmenopausal women (webappendix pp 3,4). This evidence concerns the gene IGFBP3 and breast carcinoma.